• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 FDG-PET/CT 影像与临床资料的多任务贝叶斯模型用于可解释的高级别前列腺癌预后预测。

Multi-task Bayesian model combining FDG-PET/CT imaging and clinical data for interpretable high-grade prostate cancer prognosis.

机构信息

Département de physique, de génie physique et d'optique, et Centre de recherche sur le cancer, Université Laval, Québec, QC, Canada.

CHU de Québec - Université Laval et CRCHU de Québec, Québec, QC, Canada.

出版信息

Sci Rep. 2024 Nov 6;14(1):26928. doi: 10.1038/s41598-024-77498-0.

DOI:10.1038/s41598-024-77498-0
PMID:39505979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11541986/
Abstract

We propose a fully automatic multi-task Bayesian model, named Bayesian Sequential Network (BSN), for predicting high-grade (Gleason   8) prostate cancer (PCa) prognosis using pre-prostatectomy FDG-PET/CT images and clinical data. BSN performs one classification task and five survival tasks: predicting lymph node invasion (LNI), biochemical recurrence-free survival (BCR-FS), metastasis-free survival, definitive androgen deprivation therapy-free survival, castration-resistant PCa-free survival, and PCa-specific survival (PCSS). Experiments are conducted using a dataset of 295 patients. BSN outperforms widely used nomograms on all tasks except PCSS, leveraging multi-task learning and imaging data. BSN also provides automated prostate segmentation, uncertainty quantification, personalized feature-based explanations, and introduces dynamic predictions, a novel approach that relies on short-term outcomes to refine long-term prognosis. Overall, BSN shows great promise in its ability to exploit imaging and clinicopathological data to predict poor outcome patients that need treatment intensification with loco-regional or systemic adjuvant therapy for high-risk PCa.

摘要

我们提出了一种全自动多任务贝叶斯模型,命名为贝叶斯序列网络(BSN),用于使用前列腺切除术前行 FDG-PET/CT 图像和临床数据预测高级别(Gleason 8)前列腺癌(PCa)预后。BSN 执行一个分类任务和五个生存任务:预测淋巴结侵犯(LNI)、生化无复发生存(BCR-FS)、无转移生存、确定性雄激素剥夺治疗无复发生存、去势抵抗性 PCa 无复发生存和 PCa 特异性生存(PCSS)。实验使用 295 名患者的数据集进行。BSN 在所有任务上的表现都优于广泛使用的列线图,除了 PCSS,它利用多任务学习和成像数据。BSN 还提供了自动前列腺分割、不确定性量化、基于个性化特征的解释,并引入了动态预测,这是一种依赖短期结果来改进长期预后的新方法。总的来说,BSN 具有利用成像和临床病理数据预测需要局部或全身辅助治疗强化治疗的高危 PCa 预后不良患者的巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/e25efe1cf66c/41598_2024_77498_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/30e57cd433c0/41598_2024_77498_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/ea191a730ebf/41598_2024_77498_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/4e1bbc30b2d4/41598_2024_77498_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/20566159189c/41598_2024_77498_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/38d6a57db4ca/41598_2024_77498_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/998f8944c077/41598_2024_77498_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/af910a863172/41598_2024_77498_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/daa5fa6914d8/41598_2024_77498_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/e25efe1cf66c/41598_2024_77498_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/30e57cd433c0/41598_2024_77498_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/ea191a730ebf/41598_2024_77498_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/4e1bbc30b2d4/41598_2024_77498_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/20566159189c/41598_2024_77498_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/38d6a57db4ca/41598_2024_77498_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/998f8944c077/41598_2024_77498_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/af910a863172/41598_2024_77498_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/daa5fa6914d8/41598_2024_77498_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12c6/11541986/e25efe1cf66c/41598_2024_77498_Fig9_HTML.jpg

相似文献

1
Multi-task Bayesian model combining FDG-PET/CT imaging and clinical data for interpretable high-grade prostate cancer prognosis.基于 FDG-PET/CT 影像与临床资料的多任务贝叶斯模型用于可解释的高级别前列腺癌预后预测。
Sci Rep. 2024 Nov 6;14(1):26928. doi: 10.1038/s41598-024-77498-0.
2
Increased Prostate Cancer Glucose Metabolism Detected by F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Localised Gleason 8-10 Prostate Cancers Identifies Very High-risk Patients for Early Recurrence and Resistance to Castration.F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描检测到的局部格里森 8-10 前列腺癌葡萄糖代谢增加,可识别出早期复发和对去势治疗耐药的极高风险患者。
Eur Urol Focus. 2019 Nov;5(6):998-1006. doi: 10.1016/j.euf.2018.03.008. Epub 2018 Mar 30.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
GLUT1 expression in high-risk prostate cancer: correlation with F-FDG-PET/CT and clinical outcome.GLUT1 在高危前列腺癌中的表达:与 F-FDG-PET/CT 的相关性及其临床结局。
Prostate Cancer Prostatic Dis. 2020 Sep;23(3):441-448. doi: 10.1038/s41391-020-0202-x. Epub 2020 Jan 13.
5
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.术前 3-T 多参数 MRI 和 Ga-PSMA PET/CT 扫描对前列腺癌根治性前列腺切除术和盆腔淋巴结清扫术病理结果的预测价值的组织学比较。
BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7.
6
FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描用于活检确诊的高级别前列腺癌患者的术前分期和预后分层。
Cancer Imaging. 2015 Mar 3;15(1):2. doi: 10.1186/s40644-015-0038-0.
7
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.基于术前前列腺特异膜抗原正电子发射断层扫描识别行扩大盆腔淋巴结清扫术的前列腺癌患者最佳淋巴结分期候选者:纪念斯隆凯特琳癌症中心和布里甘蒂列线图的外部验证及新型工具的开发。
Eur Urol Oncol. 2023 Dec;6(6):543-552. doi: 10.1016/j.euo.2023.05.003. Epub 2023 Jun 1.
8
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters.哪些接受术前前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描检查时存在淋巴结摄取的前列腺癌患者在根治性前列腺切除术后前列腺特异性抗原持续存在的风险更高?通过整合临床、磁共振成像和功能成像参数来确定系统性疾病的指标。
Eur Urol Oncol. 2024 Apr;7(2):231-240. doi: 10.1016/j.euo.2023.08.010. Epub 2023 Sep 9.
9
Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor Quantification and Prognosis of Cancer on PET/CT.基于深度半监督迁移学习的全身肿瘤全自动定量及 PET/CT 预测癌症预后
J Nucl Med. 2024 Apr 1;65(4):643-650. doi: 10.2967/jnumed.123.267048.
10
Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen ( Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection.根治性前列腺切除术后加病理阳性淋巴结清扫术,前列腺特异性膜抗原(Ga-PSMA)正电子发射/计算机断层扫描后前列腺癌复发的分布。
BJU Int. 2020 Jun;125(6):876-883. doi: 10.1111/bju.15052. Epub 2020 Apr 23.

本文引用的文献

1
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
2
survex: an R package for explaining machine learning survival models.survex:一个用于解释机器学习生存模型的 R 包。
Bioinformatics. 2023 Dec 1;39(12). doi: 10.1093/bioinformatics/btad723.
3
Diagnostic Performance and Safety of Positron Emission Tomography with F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
F-rhPSMA-7.3 正电子发射断层扫描在初诊不利中高危前列腺癌患者中的诊断性能和安全性:一项 3 期前瞻性多中心研究(LIGHTHOUSE)的结果。
Eur Urol. 2023 Oct;84(4):361-370. doi: 10.1016/j.eururo.2023.06.018. Epub 2023 Jul 5.
4
Integrating CT-based radiomic model with clinical features improves long-term prognostication in high-risk prostate cancer.将基于CT的影像组学模型与临床特征相结合可改善高危前列腺癌的长期预后。
Front Oncol. 2023 Apr 27;13:1060687. doi: 10.3389/fonc.2023.1060687. eCollection 2023.
5
Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography.基于磁共振成像和前列腺特异性膜抗原正电子发射断层扫描分子成像的新型列线图预测前列腺癌患者盆腔淋巴结转移概率的建立与外部验证
Eur Urol Oncol. 2023 Dec;6(6):553-563. doi: 10.1016/j.euo.2023.03.010. Epub 2023 Apr 10.
6
Deep learning model integrating positron emission tomography and clinical data for prognosis prediction in non-small cell lung cancer patients.深度学习模型整合正电子发射断层扫描和临床数据,用于非小细胞肺癌患者的预后预测。
BMC Bioinformatics. 2023 Feb 6;24(1):39. doi: 10.1186/s12859-023-05160-z.
7
Tackling prediction uncertainty in machine learning for healthcare.解决医疗保健机器学习中的预测不确定性。
Nat Biomed Eng. 2023 Jun;7(6):711-718. doi: 10.1038/s41551-022-00988-x. Epub 2022 Dec 29.
8
Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer.基于机器学习的多模态数据整合提高了高级别浆液性卵巢癌的风险分层。
Nat Cancer. 2022 Jun;3(6):723-733. doi: 10.1038/s43018-022-00388-9. Epub 2022 Jun 28.
9
Explainable deep learning in healthcare: A methodological survey from an attribution view.医疗保健中的可解释深度学习:基于归因视角的方法学综述
WIREs Mech Dis. 2022 May;14(3):e1548. doi: 10.1002/wsbm.1548. Epub 2022 Jan 17.
10
An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT.转移性前列腺癌新分子通路的研究进展:聚焦 DDR、MSI 和 AKT
Int J Mol Sci. 2021 Dec 16;22(24):13519. doi: 10.3390/ijms222413519.